Invesco Ltd. Amneal Pharmaceuticals, Inc. Transaction History

Invesco Ltd.

$460 Billion
Q2 2024

A detailed history of Invesco Ltd. transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 1,178,379 shares of AMRX stock, worth $10.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,178,379

Previous 1,245,815 5.41%

Holding current value

$10.4 Million

Previous $7.55 Million 0.89%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$5.36 - $7.11 $361,456 - $479,469	-67,436 Reduced 5.41%	1,178,379 $7.48 Million
Q1 2024 May 14, 2024	SELL	$5.24 - $6.34 $1.17 Million - $1.42 Million	-223,710 Reduced 15.22%	1,245,815 $7.55 Million
Q4 2023 Feb 12, 2024	BUY	$3.36 - $6.21 $3.53 Million - $6.53 Million	1,051,649 Added 251.67%	1,469,525 $8.92 Million
Q3 2023 Nov 13, 2023	BUY	$2.76 - $4.59 $70,573 - $117,366	25,570 Added 6.52%	417,876 $1.76 Million
Q2 2023 Aug 11, 2023	SELL	$1.33 - $3.1 $22,669 - $52,839	-17,045 Reduced 4.16%	392,306 $1.22 Million
Q1 2023 May 12, 2023	BUY	$1.27 - $2.7 $652 - $1,387	514 Added 0.13%	409,351 $568,000
Q4 2022 Feb 13, 2023	BUY	$1.96 - $2.61 $314,217 - $418,422	160,315 Added 64.51%	408,837 $813,000
Q3 2022 Nov 14, 2022	SELL	$2.02 - $3.62 $33,265 - $59,614	-16,468 Reduced 6.21%	248,522 $502,000
Q2 2022 Aug 15, 2022	BUY	$3.01 - $4.46 $165,721 - $245,554	55,057 Added 26.23%	264,990 $843,000
Q1 2022 May 16, 2022	BUY	$3.9 - $4.89 $63,269 - $79,330	16,223 Added 8.37%	209,933 $875,000
Q4 2021 Feb 14, 2022	SELL	$3.95 - $5.85 $37,165 - $55,042	-9,409 Reduced 4.63%	193,710 $928,000
Q3 2021 Nov 15, 2021	SELL	$4.31 - $5.64 $302,006 - $395,200	-70,071 Reduced 25.65%	203,119 $1.09 Million
Q2 2021 Aug 17, 2021	BUY	$5.12 - $6.82 $277,719 - $369,930	54,242 Added 24.77%	273,190 $1.4 Million
Q1 2021 May 17, 2021	BUY	$4.74 - $7.38 $40,422 - $62,936	8,528 Added 4.05%	218,948 $1.47 Million
Q4 2020 Feb 16, 2021	SELL	$3.95 - $5.42 $189,919 - $260,599	-48,081 Reduced 18.6%	210,420 $961,000
Q3 2020 Nov 16, 2020	SELL	$3.54 - $5.27 $341,546 - $508,460	-96,482 Reduced 27.18%	258,501 $1 Million
Q2 2020 Aug 14, 2020	BUY	$2.87 - $5.46 $359,493 - $683,914	125,259 Added 54.53%	354,983 $1.69 Million
Q1 2020 May 15, 2020	BUY	$2.46 - $5.35 $448,517 - $975,433	182,324 Added 384.65%	229,724 $800,000
Q4 2019 Feb 14, 2020	SELL	$2.65 - $5.56 $7,700 - $16,157	-2,906 Reduced 5.78%	47,400 $228,000
Q3 2019 Nov 14, 2019	SELL	$2.29 - $7.1 $348,957 - $1.08 Million	-152,383 Reduced 75.18%	50,306 $146,000
Q2 2019 Aug 14, 2019	BUY	$6.44 - $14.29 $968,614 - $2.15 Million	150,406 Added 287.68%	202,689 $1.45 Million
Q1 2019 May 15, 2019	SELL	$11.87 - $14.84 $3.64 Million - $4.56 Million	-306,996 Reduced 85.45%	52,283 $741,000
Q4 2018 Feb 14, 2019	BUY	$13.09 - $21.49 $4.7 Million - $7.72 Million	359,279 New	359,279 $4.86 Million

Others Institutions Holding AMRX

# of Institutions

186

Shares Held

137M

Call Options Held

234K

Put Options Held

45.9K

View Full List

About Amneal Pharmaceuticals, Inc.

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.34B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

More about AMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account